SCHEMBL2955229

SCHEMBL2955229

CCn1c2ccc(C(=O)c3ccc(N4CCOCC4)cc3)cc2c2cc(/C(C)=N/O)ccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.62
HPGD P15428 4/20 0.62
HTT P42858 3/20 0.62
MAPT P10636 12/20 0.56
LMNA P02545 3/20 0.56
GFER P55789 1/20 0.50
KMT2A Q03164 6/20 0.47
ALDH1A1 P00352 6/20 0.47
MEN1 O00255 5/20 0.47
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
NPY5R Q15761 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2955232 1.00 KDM4E (0.62) KDM4EHPGDHTTMAPTLMNA
SCHEMBL31680366 0.90 KDM4E (0.55) KDM4EHPGDHTTMAPTLMNA
SCHEMBL2945448 0.89 MAPT (0.52) KDM4EHPGDHTTMAPTLMNA
SCHEMBL10098916 0.88 MAPT (0.46) KDM4EHPGDHTTMAPTLMNA
SCHEMBL2735112 0.86 KDM4E (0.83) KDM4EHPGDHTTMAPTLMNA
SCHEMBL27988352 0.85 KDM4E (0.85) KDM4EHPGDHTTMAPTLMNA
SCHEMBL14549133 0.85 MAPT (0.49) KDM4EHPGDHTTMAPTLMNA
SCHEMBL13236626 0.85 KDM4E (0.58) KDM4EHPGDHTTMAPTLMNA
SCHEMBL3123317 0.80 KDM4E (0.74) KDM4EHPGDHTTMAPTLMNA
SCHEMBL3123320 0.80 KDM4E (0.74) KDM4EHPGDHTTMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759043-B2 Oxime ester photoinitiators CIBA SPECIALTY CHEMICALS CORP. (US) 2010-07-20 US disclosed
US-20080096115-A1 Oxime Ester Photoinitiators CIBA SPECIALTY CHEMICALS CORP. 2008-04-24 US disclosed
EP-1778636-B1 OXIME ESTER PHOTOINITIATORS CIBA SC HOLDING AG (CH) 2007-12-19 EP disclosed
EP-1778636-A1 OXIME ESTER PHOTOINITIATORS Ciba SC Holding AG (CH) 2007-05-02 EP disclosed
WO-2006018405-A1 OXIME ESTER PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096115-A1 Oxime Ester Photoinitiators NR2E3, CBR3, AHR KDM4E 989/4885HPGD 1649/4885HTT 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.